|
The tuberculosis epidemic is worsening worldwide and killed over 2 million people a year over the past several years. It is a top cause of death among people who are HIV-positive, and is becoming more dangerous with the spread of drug-resistant strains.
The World Bank has financed TB control in over 30 countries, mainly through the cost-effective Directly Observed Treatment Short (DOTS) Strategy which focuses on identifying and curing infectious patients. Total investments are now more than $560 million and include ongoing large projects in India and China - together home to over 40% of the world's TB patients. Other Bank-supported operations include a $150 million loan to the Russian Federation for TB and AIDS control and a similar loan for $60 million to Ukraine.
We are committed to responding to the global tuberculosis (TB) epidemic and do so through policy dialogue and advice, country-specific lending for health system strengthening and disease control, analytic work, and involvement in global partnerships, including the Stop TB Partnership.
|